Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benfotiamine in Type 2 Diabetes Polyneuropathy
DRKS00014832Phase 2Completed
- Sponsor
- Wörwag Pharma
- Start
- Aug 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic polyneuropathy (DPN) and type 2 diabetes mellitus (T2DM) comparing Benfotiamine (Milgamma mono 300) with Placebo (2 arms). Started Aug 2018; status: completed.
02
Drugs
benfotiamine
03
Conditions
diabetic polyneuropathy (DPN)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on DRKS00014832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00014832.